Literature DB >> 22700264

Family treatment for schizophrenia : the design and research application of therapist training models.

I R Falloon, C W McGill, S M Matthews, S J Keith, N R Schooler.   

Abstract

The NIMH Treatment Strategies in Schizophrenia (TSS) collaborative study group investigated the efficacy of antisychotic drug maintenance strategies involving reduced medication exposure in interaction with applied and supportive family management for the long-term treatment of schizophrenia. Therapy was provided at five centers by 25 clinicians who did not participate in the development of the therapies. They were trained by two of the authors, I.R.H.F and C.W.M, in applied family management, a homebased treatment derived from the behavioral family therapy developed by them. Clinicians' characteristics, selection, and training methods, as well as patient rehospitalization rates, are reported for the two family management conditions. The TSS study represents a bridge between the development of a novel therapy and its dissemination in general clinical practice.

Entities:  

Year:  1996        PMID: 22700264      PMCID: PMC3330401     

Source DB:  PubMed          Journal:  J Psychother Pract Res        ISSN: 1055-050X


  4 in total

1.  Family interventions for mental disorders: efficacy and effectiveness.

Authors:  Ian R H Falloon
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

Review 2.  Family intervention for schizophrenia.

Authors:  Fiona Pharoah; Jair Mari; John Rathbone; Winson Wong
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

Review 3.  Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation.

Authors:  Susan R McGurk; Kim T Mueser; Thomas J DeRosa; Rosemarie Wolfe
Journal:  Schizophr Bull       Date:  2009-03-05       Impact factor: 9.306

4.  Family-focused therapy for individuals at clinical high risk for psychosis: treatment fidelity within a multisite randomized trial.

Authors:  Sarah E Marvin; David J Miklowitz; Mary P O'Brien; Tyrone D Cannon
Journal:  Early Interv Psychiatry       Date:  2014-04-11       Impact factor: 2.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.